AngioDynamics (ANGO) Set to Announce Quarterly Earnings on Thursday
AngioDynamics (NASDAQ:ANGO) will be issuing its Q114 quarterly earnings data on Thursday, October 10th. Analysts expect the company to announce earnings of $0.03 per share and revenue of $82.54 million for the quarter. AngioDynamics has set its Q1 guidance at $0.02-0.04 EPS and its FY14 guidance at $0.31-0.35 EPS.
AngioDynamics (NASDAQ:ANGO) last issued its quarterly earnings data on Thursday, July 11th. The company reported $0.07 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.06 by $0.01. The company had revenue of $90.00 million for the quarter, compared to the consensus estimate of $86.43 million. During the same quarter last year, the company posted $0.09 earnings per share. AngioDynamics’s revenue was up 56.0% compared to the same quarter last year. On average, analysts expect AngioDynamics to post $0.32 EPS for the current fiscal year and $0.40 EPS for the next fiscal year.
Shares of AngioDynamics (NASDAQ:ANGO) opened at 13.81 on Wednesday. AngioDynamics has a 52 week low of $9.52 and a 52 week high of $13.98. The stock’s 50-day moving average is $12.01 and its 200-day moving average is $11.32. The company’s market cap is $482.2 million.
Several analysts have recently commented on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of AngioDynamics in a research note to investors on Tuesday, October 1st. They now have a $14.00 price target on the stock.
AngioDynamics, Inc designs manufacture and sell a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.